SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as retail investors and community members speculate on a potential short squeeze, fueled by a high short interest and rumors of a buyout to take the company private. The discourse is further amplified by excitement over new management hires, with many users drawing parallels to past meme stock movements.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is surging as investors react to analyst optimism regarding the company's AI-ready data center pipeline and its strategic positioning to benefit from growing energy demand. The community is actively debating the timing of potential lease agreements, with bulls pointing to the upcoming Russell 3000 inclusion and government support for nuclear-powered AI infrastructure as key catalysts for sustained long-term growth.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense selling pressure as investors rotate away from high-multiple AI growth stocks amid broad sector volatility. The community remains deeply divided, with bears pointing to overvaluation and bearish momentum, while long-term bulls view the recent price correction and strategic partnerships as a generational buying opportunity.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems shares are facing volatility as the market scrutinizes the company's first public earnings report, which featured strong revenue growth but a warning regarding shrinking margins. Community members are actively debating the stock's high valuation relative to its current revenue, the long-term impact of its major cloud and AI partnerships, and the potential selling pressure from upcoming insider lockup expirations.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing significant volatility driven by shifting expectations surrounding federal interest rate policy, geopolitical tensions in the Middle East, and ongoing industrial demand. Community discourse is sharply divided between investors betting on a long-term supply deficit in industrial sectors like solar and robotics and those frustrated by the asset's failure to perform as a consistent inflationary hedge.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors monitor ongoing litigation with Nippon Shinyaku while eagerly anticipating the upcoming August PDUFA date for deramiocel. The community remains intensely focused on the potential for a favorable court ruling to restore distribution rights and the broader implications of recent FDA activity regarding other rare disease therapies.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF is attracting intense debate as investors weigh significant capital expenditure cycles against technical signals that suggest potential buy-side exhaustion or a pivotal structural juncture. Community sentiment remains divided between those viewing the basket as a critical flight-to-safety trade and others expressing deep skepticism regarding the sustainability of the underlying AI-focused revenue models.

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Absci Corp

Absci Corp is gaining momentum as investors track its AI-driven drug discovery platform and upcoming clinical readouts, fueled by recent strategic partnerships and active institutional accumulation. The community is focused on the potential of the ABS-201 program and a broader rotation into biotech-tech plays, leading to active debate over whether this represents a genuine breakout or speculative volatility.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing strong momentum as investors react to leaked information regarding GTA VI pre-order dates and anticipation for a new trailer release. The community is actively discussing the stock as a prime hedge against broader market volatility, with many positioning themselves long ahead of the game's official November launch.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending as investors monitor ongoing e-commerce regulatory scrutiny and recent EU expansion probes, while the community remains divided over its long-term viability given the stock's significant underperformance compared to broader market gains. While some participants are actively accumulating shares based on deep-value fundamentals and strong cash positions, many others are expressing frustration over the company's lack of consistent price appreciation and the perceived risks associated with the broader Chinese equity sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire CLEARWATER, Fla., May 27, 2026 CLEARWATER...

Apyx Medical (APYX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of +54.55% and +6.23%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Perrigo (PRGO) Q1 Earnings Beat Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of +10.26% and -4.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC

AIGH Capital Management LLC bought a new position in shares of Apyx Medical Corporation (NASDAQ:APYX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,104,970 shares of the company's stock, valued at approximately $3,867,000. A...

Apyx Medical (APYX) Expected to Announce Earnings on Thursday

Apyx Medical (NASDAQ:APYX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-apyx-medical-co-stock...

Apyx Medical Corporation (NASDAQ:APYX) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold...

Apyx Medical (NASDAQ:APYX) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen lowered shares of Apyx Medical from a "buy" rating to a "hold" rating in a research note on Sunday...

Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?

Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.

Apyx Medical (NASDAQ:APYX) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Apyx Medical from a "hold" rating to a "buy" rating in a research report on Saturday...

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Apyx Medical Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

APYXApyx Medical Corp

Fundamentals

Latest APYX News